These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 10773104

  • 1. Cyclical etidronate therapy for prevention of postmenopausal bone loss: a 1-year open-label follow-up study.
    Fogelman I, Herd RJ, Blake GM, Balena R.
    Calcif Tissue Int; 2000 May; 66(5):348-54. PubMed ID: 10773104
    [Abstract] [Full Text] [Related]

  • 2. Prevention of early postmenopausal bone loss with cyclical etidronate therapy (a double-blind, placebo-controlled study and 1-year follow-up).
    Meunier PJ, Confavreux E, Tupinon I, Hardouin C, Delmas PD, Balena R.
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2784-91. PubMed ID: 9284696
    [Abstract] [Full Text] [Related]

  • 3. Cyclical etidronate plus ergocalciferol prevents glucocorticoid-induced bone loss in postmenopausal women.
    Diamond T, McGuigan L, Barbagallo S, Bryant C.
    Am J Med; 1995 May; 98(5):459-63. PubMed ID: 7733124
    [Abstract] [Full Text] [Related]

  • 4. The prevention of early postmenopausal bone loss by cyclical etidronate therapy: a 2-year, double-blind, placebo-controlled study.
    Herd RJ, Balena R, Blake GM, Ryan PJ, Fogelman I.
    Am J Med; 1997 Aug; 103(2):92-9. PubMed ID: 9274891
    [Abstract] [Full Text] [Related]

  • 5. Cyclical etidronate in the treatment of postmenopausal osteoporosis: efficacy and safety after seven years of treatment.
    Miller PD, Watts NB, Licata AA, Harris ST, Genant HK, Wasnich RD, Ross PD, Jackson RD, Hoseyni MS, Schoenfeld SL, Valent DJ, Chesnut CH.
    Am J Med; 1997 Dec; 103(6):468-76. PubMed ID: 9428829
    [Abstract] [Full Text] [Related]

  • 6. Prevention of early postmenopausal bone loss with cyclical etidronate.
    Adami S, Bruni V, Bianchini D, Becorpi A, Lombardi P, Campagnoli C, Ferrari A, Marchesoni T, Balena R.
    J Endocrinol Invest; 2000 May; 23(5):310-6. PubMed ID: 10882149
    [Abstract] [Full Text] [Related]

  • 7. Cyclical etidronate reverses bone loss of the spine and proximal femur in patients with established corticosteroid-induced osteoporosis.
    Struys A, Snelder AA, Mulder H.
    Am J Med; 1995 Sep; 99(3):235-42. PubMed ID: 7653482
    [Abstract] [Full Text] [Related]

  • 8. Alendronate increases spine and hip bone mineral density in women with postmenopausal osteoporosis who failed to respond to intermittent cyclical etidronate.
    Watts NB, Becker P.
    Bone; 1999 Jan; 24(1):65-8. PubMed ID: 9916786
    [Abstract] [Full Text] [Related]

  • 9. Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephrotic patients receiving high-dose glucocorticoid and one-cycle etidronate therapy.
    Fujita T, Satomura A, Hidaka M, Ohsawa I, Endo M, Ohi H.
    Calcif Tissue Int; 2000 Mar; 66(3):195-9. PubMed ID: 10666494
    [Abstract] [Full Text] [Related]

  • 10. The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma: longitudinal evaluation and response to intermittent cyclic etidronate therapy.
    Diamond T, Campbell J, Bryant C, Lynch W.
    Cancer; 1998 Oct 15; 83(8):1561-6. PubMed ID: 9781950
    [Abstract] [Full Text] [Related]

  • 11. A double blind placebo controlled study to determine the effects of intermittent cyclical etidronate on bone mineral density in patients on long-term oral corticosteroid treatment.
    Pitt P, Li F, Todd P, Webber D, Pack S, Moniz C.
    Thorax; 1998 May 15; 53(5):351-6. PubMed ID: 9708225
    [Abstract] [Full Text] [Related]

  • 12. Intermittent Etidronate partially prevents bone loss in hirsute hyperandrogenic women treated with GnRH agonist.
    Zamberlan N, Castello R, Gatti D, Rossini M, Braga V, Fracassi E, Adami S.
    Osteoporos Int; 1997 May 15; 7(2):133-7. PubMed ID: 9166393
    [Abstract] [Full Text] [Related]

  • 13. A comparison of continuous alendronate, cyclical alendronate and cyclical etidronate with calcitriol in the treatment of postmenopausal vertebral osteoporosis: a randomized controlled trial.
    Sahota O, Fowler I, Blackwell PJ, Lawson N, Cawte SA, San P, Masud T, Hosking DJ.
    Osteoporos Int; 2000 May 15; 11(11):959-66. PubMed ID: 11193249
    [Abstract] [Full Text] [Related]

  • 14. Effects of cyclical etidronate combined with calcitriol versus cyclical etidronate alone on spine and femoral neck bone mineral density in postmenopausal osteoporotic women.
    Masud T, Mulcahy B, Thompson AV, Donnelly S, Keen RW, Doyle DV, Spector TD.
    Ann Rheum Dis; 1998 Jun 15; 57(6):346-9. PubMed ID: 9771208
    [Abstract] [Full Text] [Related]

  • 15. Effects of cyclical etidronate with alfacalcidol on lumbar bone mineral density, bone resorption, and back pain in postmenopausal women with osteoporosis.
    Iwamoto J, Takeda T, Ichimura S, Matsu K, Uzawa M.
    J Orthop Sci; 2003 Jun 15; 8(4):532-7. PubMed ID: 12898306
    [Abstract] [Full Text] [Related]

  • 16. Five years of clinical experience with intermittent cyclical etidronate for postmenopausal osteoporosis.
    Storm T, Kollerup G, Thamsborg G, Genant HK, Sørensen OH.
    J Rheumatol; 1996 Sep 15; 23(9):1560-4. PubMed ID: 8877926
    [Abstract] [Full Text] [Related]

  • 17. A four-year randomized controlled trial of hormone replacement and bisphosphonate, alone or in combination, in women with postmenopausal osteoporosis.
    Wimalawansa SJ.
    Am J Med; 1998 Mar 15; 104(3):219-26. PubMed ID: 9552083
    [Abstract] [Full Text] [Related]

  • 18. Randomized trial of effect of cyclical etidronate in the prevention of corticosteroid-induced bone loss. Ciblos Study Group.
    Roux C, Oriente P, Laan R, Hughes RA, Ittner J, Goemaere S, Di Munno O, Pouillès JM, Horlait S, Cortet B.
    J Clin Endocrinol Metab; 1998 Apr 15; 83(4):1128-33. PubMed ID: 9543129
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of the efficacy of etidronate therapy in preventing glucocorticoid-induced bone loss in patients with inflammatory rheumatic diseases. A randomized study.
    Cortet B, Hachulla E, Barton I, Bonvoisin B, Roux C.
    Rev Rhum Engl Ed; 1999 Apr 15; 66(4):214-9. PubMed ID: 10339777
    [Abstract] [Full Text] [Related]

  • 20. Cyclical etidronate increases bone density in the spine and hip of postmenopausal women receiving long term corticosteroid treatment. A double blind, randomised placebo controlled study.
    Geusens P, Dequeker J, Vanhoof J, Stalmans R, Boonen S, Joly J, Nijs J, Raus J.
    Ann Rheum Dis; 1998 Dec 15; 57(12):724-7. PubMed ID: 10070271
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.